In this episode presented by DIA, BioSpace's head of insights Lori Ellis discusses the evolution of women's inclusion in ...

Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of ...

This article is authored by Dr YK Gupta, president, AIIMS, Jammu and Ankush Kapoor, founder & CEO, Pharma NXT Biotech.

The general mood among these heavyweight investors is divided, with 44% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $256,004, and 4 are calls, amounting to ...

Mr. Tarun Thapar, A veteran in Blank Artillery shell manufacturing in India has been appointed as ED technical in SUNITA ...

At the show, Synchron demonstrated how its Stentrode BCI, a stent-like device implanted via the neck into blood vessels near ...

Insolation Energy Limited have been awarded Letter of Award (LOA) by Rajasthan Renewable Energy Corporation Limited (RREC) ...

Indeed, hematologists expect biosimilars’ arrival may in fact grow the overall ... include year over year trending to quantify key aspects of market evolution, and integrate specialists’ attitudinal & ...

The FDA defines a biosimilar as a biological product that is highly similar to an FDA-approved brand-name biologic drug (known as the reference product) used in the prevention or treatment of disease.

Objectives: Biosimilars offer a promising solution to challenges related to healthcare budget sustainability. However, limited patient awareness and understanding often hinder their timely adoption.

To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and user-friendly diagnostic methods are key. People living with HIV face ...

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s OMLYCLO (omalizumab-igec) as the first and only biosimilar designated as interchangeable with XOLAIR (omalizumab) for the treatment ...